PCMU
BIIB icon

Paragon Capital Management (Utah)’s Biogen BIIB Stock Holding History

Paragon Capital Management (Utah)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,686
Closed -$1.18M – 73
2025
Q4 		$1.18M Buy
+6,686
New +$1.09M 0.91% 43
2023
Q2 		– Sell
-6,715
Closed -$1.87M – 71
2023
Q1 		$1.87M Buy
6,715
+3,063
+84% +$848K 1.63% 13
2022
Q4 		$1.01M Buy
+3,652
New +$1.03M 0.94% 46

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paragon Capital Management (Utah)'s BIIB Position: Q1 2026 in Review

Paragon Capital Management (Utah) sold out of Biogen (BIIB) in Q1 2026, closing a stake of 6,686 shares — an estimated $1.18M sold.

Paragon Capital Management (Utah) first reported a position in BIIB in Q4 2022 and held it in 3 quarters. The position peaked at $1.87M in Q1 2023. 1,005 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Paragon Capital Management (Utah) reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 6,686 Biogen shares in Q1 2026, an estimated $1.18M.
  • Paragon Capital Management (Utah) first reported a position in Biogen in Q4 2022 and held it in 3 quarters.
  • Paragon Capital Management (Utah)'s Biogen position peaked at $1.87M in Q1 2023.
  • 1,005 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Paragon Capital Management (Utah)'s 13F filing for Q1 2026, filed 17 Apr 2026.